Ronald Kenneth Fisher Jr. - 09 Aug 2022 Form 4 Insider Report for SIGMA LABS, INC. (NTRP)

Reporting relationship: VP of Business Development
Issuer ticker: NTRP
Reported as of: 09 Aug 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2022, 21:00:36 UTC
Prior SEC filing: 06 Jul 2022
Source filing: View source filing
Reporting owner signature: /s/ Ronald Fisher

Key filing fact

Ronald Kenneth Fisher Jr. filed Form 4 for SIGMA LABS, INC. (NTRP) on 11 Aug 2022.

Key facts

This page summarizes Ronald Kenneth Fisher Jr.'s Form 4 filing for SIGMA LABS, INC. (NTRP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Aug 2022, 21:00.

Change

Previous filing in this sequence was filed on 06 Jul 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SASI transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +1,751
Change %
Price: $0.000000
Shares after: 1,751
Date: 09 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,751
Exercise price: $2.50
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on August 9, 2022.

Footnote F2

The stock option vests as follows: (i) 438 shares subject to the option vested on the date of grant, and (ii) the remaining 1,313 shares will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.